{
  "abstract": "Substance use disorders may arise when individuals use substances to cope with adverse mental health symptoms. Conversely, mental health symptoms can develop because of substance use, a category of conditions called substance-induced disorders. This study used two United States-based datasets, the Mental Health Client-Level Data and the Treatment Episode Data Set Admissions, to summarize the number of cases with “alcohol-induced disorders” and “substance-induced disorders” from both mental health and substance use disorder treatment programs from 2013 to 2022. The primary study aim was to identify the percentage of cases with alcohol-induced disorders or substance-induced disorders in these treatment settings. Among all mental health disorder treatment cases, those with an alcohol or substance-induced disorder totaled N = 439,932, making up 0.7% of total cases over the analytic period. During the same period, alcohol or substance-induced disorders totaled N = 459,817, accounting for approximately 2.7% of all substance use disorder treatment cases. The majority (79%) of cases with an alcohol-induced disorder in substance use disorder treatment were identified as reporting alcohol use, with 68% having alcohol listed as their primary substance. Heroin and other opiates and synthetics accounted for the primary substance among 28.8% of cases with a substance-induced disorder in the substance use disorder treatment data. Approximately 1 in 3 cases with an alcohol-induced disorder and 1 in 4 cases with a substance-induced disorder had a depressive disorder diagnosis in mental health treatment. When considering the primary diagnosis, approximately 1 in 4 cases with an alcohol-induced disorder and 15% of cases with a substance-induced disorder had a depressive disorder as the primary diagnosis in mental health treatment. Substance-induced disorders are a significant public health concern, and more research is needed to better understand the clinical needs of this population.",
  "abstract_shown": true,
  "affiliations": [
    "School of Social Work, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America"
  ],
  "article_type": "Research Article",
  "arxiv": null,
  "author_total": 1,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Orrin D. Ware"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/ftg2zvehv1f3d.bib",
  "cited_by": 0,
  "doi": "10.1371/journal.pmen.0000706",
  "fulltext_url": "https://journals.plos.org/mentalhealth/article?id=10.1371/journal.pmen.0000706",
  "id": "ftg2zvehv1f3d",
  "issns": [
    "2837-8156"
  ],
  "landing_url": "https://journals.plos.org/mentalhealth/article?id=10.1371/journal.pmen.0000706",
  "language": null,
  "licence": "CC-BY-4.0",
  "licence_label": "CC BY 4.0",
  "licence_source": "journal",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "openalex",
      "2713|Substance Abuse Treatment and Outcomes"
    ],
    [
      "plos",
      "/Biology and life sciences/Psychology/Addiction/Alcoholism"
    ],
    [
      "plos",
      "/Biology and life sciences/Psychology/Addiction/Drug addiction"
    ],
    [
      "plos",
      "/Medicine and health sciences/Diagnostic medicine"
    ],
    [
      "plos",
      "/Medicine and health sciences/Mental health and psychiatry"
    ],
    [
      "plos",
      "/Medicine and health sciences/Mental health and psychiatry/Mental health therapies"
    ],
    [
      "plos",
      "/Medicine and health sciences/Mental health and psychiatry/Mood disorders/Depression"
    ],
    [
      "plos",
      "/Medicine and health sciences/Mental health and psychiatry/Schizophrenia"
    ],
    [
      "plos",
      "/Medicine and health sciences/Mental health and psychiatry/Substance-related disorders/Alcoholism"
    ],
    [
      "plos",
      "/Medicine and health sciences/Mental health and psychiatry/Substance-related disorders/Drug addiction"
    ],
    [
      "plos",
      "/Medicine and health sciences/Pharmaceutics/Drug therapy/Neurological drug therapy/Anti-addiction drug therapy/Nicotine replacement therapy"
    ],
    [
      "plos",
      "/Medicine and health sciences/Public and occupational health/Substance-related disorders/Alcoholism"
    ],
    [
      "plos",
      "/Medicine and health sciences/Public and occupational health/Substance-related disorders/Drug addiction"
    ],
    [
      "plos",
      "/Social sciences/Psychology/Addiction/Alcoholism"
    ],
    [
      "plos",
      "/Social sciences/Psychology/Addiction/Drug addiction"
    ]
  ],
  "openalex": "W7168235145",
  "pdf_url": "https://journals.plos.org/mentalhealth/article/file?id=10.1371/journal.pmen.0000706&type=printable",
  "pmcid": null,
  "pmid": null,
  "published": "2026-09-02",
  "publisher": "Public Library of Science",
  "ris": "https://research.draconitic.com/paper/ftg2zvehv1f3d.ris",
  "sources": [
    {
      "first_seen": "2026-10-30T12:18:02Z",
      "native_id": "10.1371/journal.pmen.0000706",
      "source": "plos",
      "url": "https://journals.plos.org/mentalhealth/article?id=10.1371/journal.pmen.0000706"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "plos:mental health and psychiatry",
      "subfield": "psychiatry"
    }
  ],
  "title": "Alcohol and substance-induced disorder treatment cases in mental health and addiction treatment facilities from 2013 to 2022: A descriptive study",
  "title_text": "Alcohol and substance-induced disorder treatment cases in mental health and addiction treatment facilities from 2013 to 2022: A descriptive study",
  "type": "peer-reviewed",
  "updated_at": "2026-10-30T12:18:02Z",
  "url": "https://research.draconitic.com/paper/ftg2zvehv1f3d",
  "venue": "PLOS Mental Health",
  "versions": []
}